describing Isis Alnylam

Related by string. * de scribed . Describing . Described . DESCRIBED : TARDED WHEN DESCRIBING HER . described gambler Howie . described utter obliteration . accompanying prospectus describing / ISi . ISIS . isi . ISID : Avid Unity ISIS . DG ISI . FULL TEXT ISI PUBMED . CrossRef ISI Medline / : comprise Alnylam RNAi . Alnylam dependence . Alnylam maintains . formed Alnylam Biotherapeutics * *

Related by context. Frequent words. (Click for all words.) 59 Regulus 56 within themeaning 55 uncertainties materializes FICO 54 GSI Commerce expressly disclaims 54 FICO disclaims 53 forward.looking statements 52 acquisitions mergers dispositions 52 RR Donnelley disclaims 52 ACS disclaims 52 ATK undertakes 51 TranSwitch indebtedness 50 Silicon Image assumes 50 SAFE HARBOR Certain 50 CAUTIONARY STATEMENT 50 Statements Certain 50 concerning Alnylam 50 intents beliefs 49 suchforward looking 49 forward lookingstatements 49 BioSante undertakes 49 risks anduncertainties 49 theforward looking 48 Regulus Therapeutics LLC 48 RXi Pharmaceutical Corporation 47 Statements Statements 47 VeriSign undertakes 47 NYSE Euronext disclaims 47 Mannatech objectives 47 Medtronic Annual Report 47 Nortel strategic alliances 46 Brightpoint undertakes 46 Nanobac Pharmaceuticals Inc. 46 Ibis Biosciences Inc. 46 Streetinvesting.com undertakes 46 Regulus Therapeutics 46 www.norsat.com 46 Medtronic periodic 45 Helix BioMedix Inc. 45 month Neill Culina 45 Takeda Kyowa Hakko Kirin 45 Furthermore Cephalon 45 Calpine undertakes 45 Syntonix 45 BSB Race 45 Genelabs 45 Hybridon 45 Resverlogix Corp. 45 Omniture undertakes 44 Nuinsco believes 44 Isis Pharmaceuticals 44 FirstEnergy expressly disclaims 44 TranSwitch filings 44 Tranzyme Pharma 44 Protox 44 OctoPlus NV 44 FermaVir 44 goals expectations anticipations 44 transportation storage terminalling 44 Archemix 44 Develop Novel 43 Viral Genetics 43 OncoMed Pharmaceuticals 43 Pervasive assumes 43 differmaterially 43 Assumptions relating 43 Opexa Therapeutics 43 Myrexis 43 Announces FDA Clearance 43 Azixa ™ 43 reflect Sentry Select 43 alteration widespread 43 forwardlooking statements 43 Redishred 42 Genetronics 42 Eligard R 42 should consult Cytokinetics 42 involves specifying 42 www.axmininc.com 42 ChemoCentryx 42 ESBATech 42 Chromos 42 Nventa 42 Molecular Insight 42 InSite Vision 42 peptide compounds 42 Limited NYSE YGE 42 party VLSI fabrication 42 Daytrana TM 42 objectives expectations anticipations 41 geology continuity 41 Lpath 41 BlackRock cautions 41 Idera Pharmaceuticals 41 CorMedix 41 Corautus 41 Myriad Pharmaceuticals 41 incur unanticipated 41 Caprion 41 PsychoGenics 41 timelines communicated 41 Johnnie Walker Guinness Smirnoff

Back to home page